Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 20, 2021

SELL
$29.97 - $36.66 $1.1 Million - $1.35 Million
-36,725 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$25.39 - $32.61 $26,024 - $33,425
1,025 Added 2.87%
36,725 $1.12 Million
Q4 2020

Feb 17, 2021

SELL
$12.16 - $19.77 $8.15 Million - $13.3 Million
-670,268 Reduced 94.94%
35,700 $706,000
Q4 2020

Feb 16, 2021

BUY
$12.16 - $19.77 $8.58 Million - $14 Million
705,968 New
705,968 $706,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.25B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Summer Haven Investment Management, LLC Portfolio

Follow Summer Haven Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summer Haven Investment Management, LLC with notifications on news.